(Q34490275)

2 August 2017

title

LC/MS evaluation of metabolism and membrane transport of bombesin peptides (English)

1 reference

2 August 2017

9

Xiaoyuan Chen

1 reference

2 August 2017

8

Dale O Kiesewetter

1 reference

2 August 2017

3

Gang Niu

1 reference

2 August 2017

7

Haokao Gao

1 reference

2 August 2017

5

Lixin Lang

1 reference

2 August 2017

4

Yongjun Yan

1 reference

2 August 2017

Dongyu Gu

1

1 reference

2 August 2017

Ying Ma

series ordinal

2

1 reference

2 August 2017

Haji Akber Aisa

series ordinal

6

1 reference

2 August 2017

publication date

30 July 2010

1 reference

2 August 2017

1 reference

2 August 2017

volume

40

1 reference

2 August 2017

issue

2

1 reference

2 August 2017

page(s)

669-675

1 reference

Applications of LC-MS in PET radioligand development and metabolic elucidation

2 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3020998

Small-animal PET of tumors with (64)Cu-labeled RGD-bombesin heterodimer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3020998

In vitro and in vivo metabolism of Lu-AMBA, a GRP-receptor binding compound, and the synthesis and characterization of its metabolites

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3020998

Design and in vitro characterization of highly sst2-selective somatostatin antagonists suitable for radiotargeting

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3020998

Strategies to in vitro assessment of major human CYP enzyme activities by using liquid chromatography tandem mass spectrometry

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3020998

Gastrin-releasing peptide receptor as a molecular target in experimental anticancer therapy

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3020998

18F-labeled bombesin analogs for targeting GRP receptor-expressing prostate cancer.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3020998

Radiolabeled peptide conjugates for targeting of the bombesin receptor superfamily subtypes

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3020998

[99mTc]Demobesin 1, a novel potent bombesin analogue for GRP receptor-targeted tumour imaging

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3020998

Gastrin-releasing peptide receptors in non-neoplastic and neoplastic human breast

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3020998

Gastrin-releasing peptide receptors in the human prostate: relation to neoplastic transformation.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3020998

CD10/neutral endopeptidase 24.11 hydrolyzes bombesin-like peptides and regulates the growth of small cell carcinomas of the lung

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3020998

Dual integrin and gastrin-releasing peptide receptor targeted tumor imaging using 18F-labeled PEGylated RGD-bombesin heterodimer 18F-FB-PEG3-Glu-RGD-BBN.

6 July 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0696-Y

99mTc-labeled bombesin(7-14)NH2 with favorable properties for SPECT imaging of colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0696-Y

Comparative in vitro and in vivo evaluation of two 64Cu-labeled bombesin analogs in a mouse model of human prostate adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0696-Y

Synthesis and evaluation of bombesin derivatives on the basis of pan-bombesin peptides labeled with indium-111, lutetium-177, and yttrium-90 for targeting bombesin receptor-expressing tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0696-Y

microPET and autoradiographic imaging of GRP receptor expression with 64Cu-DOTA-[Lys3]bombesin in human prostate adenocarcinoma xenografts.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3020998

A newin vitroapproach for the simultaneous determination of phase I and phase II enzymatic activities of human hepatocyte preparations

27 October 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0696-Y

Bombesin receptor antagonists may be preferable to agonists for tumor targeting

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20676905

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Gastrin-releasing peptide receptor expression in cervical cancer

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20676905

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00726-010-0696-Y

1 reference

2 August 2017

1 reference

2 August 2017

1 reference